Literature DB >> 27676450

Relief of Xylose Binding to Cellobiose Phosphorylase by a Single Distal Mutation.

Kulika Chomvong1, Eric Lin2, Michael Blaisse3, Abigail E Gillespie4, Jamie H D Cate3,4,5.   

Abstract

Cellobiose phosphorylase (CBP) cleaves cellobiose-abundant in plant biomass-to glucose and glucose 1-phosphate. However, the pentose sugar xylose, also abundant in plant biomass, acts as a mixed-inhibitor and a substrate for the reverse reaction, limiting the industrial potential of CBP. Preventing xylose, which lacks only a single hydroxymethyl group relative to glucose, from binding to the CBP active site poses a spatial challenge for protein engineering, since simple steric occlusion cannot be used to block xylose binding without also preventing glucose binding. Using CRISPR-based chromosomal library selection, we identified a distal mutation in CBP, Y47H, responsible for improved cellobiose consumption in the presence of xylose. In silico analysis suggests this mutation may alter the conformation of the cellobiose phosphorylase dimer complex to reduce xylose binding to the active site. These results may aid in engineering carbohydrate phosphorylases for improved specificity in biofuel production, and also in the production of industrially important oligosaccharides.

Entities:  

Keywords:  cellobiose; inhibitor; phosphorylase; protein engineering; xylose

Mesh:

Substances:

Year:  2016        PMID: 27676450     DOI: 10.1021/acssynbio.6b00211

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  2 in total

Review 1.  β-Glucan phosphorylases in carbohydrate synthesis.

Authors:  Zorica Ubiparip; Marc De Doncker; Koen Beerens; Jorick Franceus; Tom Desmet
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-10       Impact factor: 4.813

Review 2.  Glycan Phosphorylases in Multi-Enzyme Synthetic Processes.

Authors:  Giulia Pergolizzi; Sakonwan Kuhaudomlarp; Eeshan Kalita; Robert A Field
Journal:  Protein Pept Lett       Date:  2017       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.